By Metro US
Posted on
LONDON (Reuters) – The Lancet medical journal said on Wednesday it will publish keenly-awaited phase 1 clinical trial data on a potential COVID-19 vaccine being developed by Astrazeneca and Oxford University on Monday.
“We expect this paper, which is undergoing final editing and preparation, to be published on Monday, July 20, for immediate release,” a spokeswoman for the journal said.
(Reporting by Kate Kelland; editing by Jonathan Oatis)
Haliburton breaks tie with 3-point play, Pacers beats Bucks 121-118 in OT to take 2-1 series lead
Oregon’s Sports Bra, a pub for women’s sports fans, plans national expansion as interest booms
The long wait for the first running back to be drafted ends with Jonathon Brooks going 46th
Defense becomes focus of NFL draft in Round 2 after Bills and Chargers get receivers early
Rory McIlroy and Shane Lowry remain tied for lead in the Zurich Classic of New Orleans
South Africa remembers an historic election every April 27. Here’s why this year is so poignant
Long lines form and frustration grows as Cuba runs short of cash
Tornadoes collapse buildings and level homes in Nebraska and Iowa
Trump promised big plans to flip Black and Latino voters. Many Republicans are waiting to see them
As border debate shifts right, Sen. Alex Padilla emerges as persistent counterforce for immigrants
Biden officials indefinitely postpone ban on menthol cigarettes amid election-year pushback
A ban in Kansas on gender-affirming care also would bar advocacy for kids’ social transitions
What to know about Bell’s palsy, the facial paralysis affecting Joel Embiid
South Korean police raid office of incoming head of doctors’ group over protracted strikes
